Position in GMAB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$39,814,358
+$6,234,199 QoQ
Shares Held
1,449,376
+15.8% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#16
of 292 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. GMAB ranks #19 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in GMAB
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,814,358 | 1,449,376 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $33,580,159 | 1,251,590 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $20,924,873 | 679,379 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $12,971,508 | 422,938 | Shares | Defined | 2025-11-03 | |
| 2023-09-30 | $165,275 | 4,686 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $177,810 | 4,678 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,474,074 | 39,038 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $29,012,415 | 684,578 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,140,212 | 564,588 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,770,545 | 577,733 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $24,002,354 | 663,415 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,293,986 | 689,939 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $30,111,965 | 689,061 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,402,246 | 695,622 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $30,025,332 | 914,570 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $41,740,660 | 1,026,578 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $37,589,279 | 1,026,749 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $34,752,906 | 1,025,462 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $22,540,798 | 1,063,747 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||